MarketPeel
Insider Trading Intelligence
JC

Jacob Chacko

ORIC
PRESIDENT AND CEO · ORIC PHARMACEUTICALS, INC. · CIK 0001608936
FILING MIX · LIFETIME40%/60%
BUYS
32
SELLS
48
TOTAL VALUE
$9.50M
COMPANIES
2
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
725,000
AVG SELL PX
$12.90
TRADE KIND
SHOWING 80 / 80
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
40 backtested trades · 8 horizons · 11 pending
Forward-return performance of every backtestable P/S trade by Jacob Chacko, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d40+67.50%+3.80%+0.06%+3.75%-1.39%1.40
14d40+80.00%+0.97%+0.36%+0.60%-4.51%0.19
30d40+65.00%-3.62%+0.64%-4.25%-18.16%-0.83
60d40+75.00%-9.22%+2.44%-11.66%-25.04%-2.50
90d40+82.50%-13.21%+3.41%-16.62%-30.87%-3.01
180d40+67.50%-24.23%+4.07%-28.30%-41.24%-5.23
1y40(5 pending)+85.71%-31.84%+3.21%-35.04%-75.36%-2.89
2y40(6 pending)+91.18%-1.95%+17.20%-19.14%-69.26%-1.09
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORIC · 675,000 shares · as of Jan 2, 2026
0205,771411,542617,312823,083202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 32 buys / 48 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Jun 17, 2026Jun 18, 2026View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
112,500112,500Jan 2, 2026Jan 6, 2026View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
675,000675,000Jan 2, 2026Jan 6, 2026View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
33,374$9.06$302.4K581,711Dec 16, 2025Dec 17, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
28,33328,334Dec 15, 2025Dec 17, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
PRESIDENT AND CEO
83,666615,085Dec 15, 2025Dec 17, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
22,0000Dec 15, 2025Dec 17, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
33,33366,667Dec 15, 2025Dec 17, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
37,461$12.32$461.5K531,419Oct 6, 2025Oct 8, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
53,001$12.05$638.8K568,880Oct 1, 2025Oct 2, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
34,538$12.01$414.7K621,881Sep 30, 2025Oct 2, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
125,000$10.80$1.35M656,419Sep 22, 2025Sep 24, 2025View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500Jun 17, 2025Jun 20, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
100,000100,000Jan 2, 2025Jan 3, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
600,000600,000Jan 2, 2025Jan 3, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
24,660$8.28$204.2K778,648Dec 16, 2024Dec 17, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
16,6670Dec 15, 2024Dec 17, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
28,33356,667Dec 15, 2024Dec 17, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
PRESIDENT AND CEO
67,000803,308Dec 15, 2024Dec 17, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
22,00022,000Dec 15, 2024Dec 17, 2024View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500May 21, 2024May 23, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
40,000$16.21$648.4K728,544Mar 6, 2024Mar 8, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
26,042$12.30$320.2K768,544Feb 7, 2024Feb 8, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
13,958$12.12$169.2K794,586Feb 6, 2024Feb 8, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
510,000510,000Jan 2, 2024Jan 3, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
85,00085,000Jan 2, 2024Jan 3, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
22,00044,000Dec 15, 2023Dec 19, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
16,66716,667Dec 15, 2023Dec 19, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
38,667823,083Dec 15, 2023Dec 19, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
14,539$8.58$124.8K808,544Dec 15, 2023Dec 19, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
20,000$8.03$160.6K800,652Jun 26, 2023Jun 28, 2023View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,000$20.05$100.3K0Apr 21, 2023Apr 25, 2023View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
5,00032,500Apr 21, 2023Apr 25, 2023View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
5,000$9.41$47.0K5,000Apr 21, 2023Apr 25, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
66,00066,000Feb 1, 2023Feb 2, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
400,000400,000Feb 1, 2023Feb 2, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
6,137$3.07$18.9K816,652Dec 15, 2022Feb 17, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
16,666822,789Dec 15, 2022Dec 16, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
5,764$3.25$18.7K817,025Dec 15, 2022Dec 16, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
16,66633,334Dec 15, 2022Dec 16, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
300,0000Jul 20, 2022Jul 21, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
437,500437,500Jul 20, 2022Jul 21, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
300,000300,000Jul 20, 2022Jul 21, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
280,0000Jul 20, 2022Jul 21, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
280,000280,000Jul 20, 2022Jul 21, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
437,5000Jul 20, 2022Jul 21, 2022View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500May 23, 2022May 25, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
76,072$2.82$214.6K802,652May 13, 2022May 13, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
69,354$2.75$190.5K726,580May 12, 2022May 13, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
304,574$2.90$883.6K657,226May 11, 2022May 13, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
50,000$4.54$227.2K352,652Mar 25, 2022Mar 25, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
42,873$5.03$215.7K302,652Mar 24, 2022Mar 25, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
257,127$4.98$1.28M259,779Mar 23, 2022Mar 25, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
300,000300,000Feb 1, 2022Feb 2, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Feb 1, 2022Feb 2, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
3,736$25.06$93.6K2,652Sep 15, 2021Sep 16, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
4,420$25.05$110.7K6,388Sep 14, 2021Sep 16, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
2,801$25.02$70.1K10,808Sep 13, 2021Sep 14, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
2,942$25.08$73.8K13,609Sep 10, 2021Sep 14, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
200$25.04$5.0K16,551Sep 8, 2021Sep 9, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
5,981$25.11$150.2K16,751Sep 7, 2021Sep 9, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
400$25.07$10.0K22,732May 27, 2021May 28, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
12$25.00$30023,132May 24, 2021May 24, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
4,790$25.20$120.7K23,144May 21, 2021May 24, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
2,468$25.07$61.9K27,934May 20, 2021May 24, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
11,132$25.37$282.4K30,602May 18, 2021May 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
200$26.03$5.2K30,402May 18, 2021May 18, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500May 17, 2021May 19, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
2,550$25.05$63.9K41,734May 17, 2021May 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
13,896$25.36$352.5K44,284May 14, 2021May 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
730$25.04$18.3K58,180May 13, 2021May 13, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
400$25.02$10.0K58,910May 12, 2021May 13, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
1,090$25.22$27.5K59,310May 11, 2021May 13, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
600$25.24$15.1K60,400Apr 30, 2021Apr 30, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
700$25.06$17.5K61,000Apr 28, 2021Apr 30, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
800$25.09$20.1K61,700Apr 1, 2021Apr 5, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
280,000280,000Feb 1, 2021Feb 2, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
President and CEO
62,5000Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
President and CEO
62,50062,500Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
437,500437,500Apr 23, 2020Apr 27, 2020View →
Other insiders · ORIC
Loading peer insiders…
About this filer
CIK 0001608936
ROLE
President and CEO
PRIMARY
ORIC
COMPANIES
2
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001608936DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback